NCT00993161

Upper Limb Evaluation in Non Ambulatory Patients With Neuromuscular Disorder

Development and Evaluation of a Clinical Test in Order Quantify Muscular Function in Upper Limb of Non Ambulatory Patients With Neuromuscular Disorder
Institut de Myologie, France·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Neuromuscular Disorders
Drug/Device/Intervention
Motriplate
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Institut de Myologie, France
Location
Garches,Paris,Paris,Paris, France
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2010
End date
May 01, 2013
Enrollment
174 participants
Primary outcome

Number of contact couples with the targets

Summary

The aim of this study is to evaluate different devices to quantify upper limb function
 (Motriplate) and strength (Myogrip, Myopinch) in non-ambulatory patients with neuromuscular
 disorder. Motriplate measures the ability of the patient to reproduce a repetitive movement
 of the wrist to push two 5cm*5cm targets during 30 seconds. One hundred patients aged 8-30
 years and 60 controls will be evaluated during twelve months (M0, M6 and M12) with theses new
 tools, and results will be compared to other testing, such as wrist, grip and pinch strength,
 taping, MFM measurement, and self evaluation of hand ability.

ICD-10 classifications
Other disorders of muscleDisorders of musclesOther specified disorders of musclePrimary disorders of musclesOther primary disorders of muscles
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT00993161
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT00993161 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de Myologie, France and is currently Completed. The study focuses on Neuromuscular Disorders. Target enrollment is 174 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.